Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merrimack Pharmaceuticals Inc | MACK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 15.1575 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.1575 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 11.53 - 15.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 15.1575 | USD |
Merrimack Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 220.07M | 14.52M | - | 0 | -1.18M | -0.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merrimack Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MACK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.11 | 15.165 | 15.11 | 15.14 | 1,107,952 | 0.0475 | 0.31% |
| 1 Month | 14.73 | 15.165 | 14.70 | 15.08 | 412,648 | 0.4275 | 2.90% |
| 3 Months | 14.69 | 15.165 | 14.60 | 14.95 | 207,531 | 0.4675 | 3.18% |
| 6 Months | 12.70 | 15.89 | 12.54 | 14.68 | 142,756 | 2.46 | 19.35% |
| 1 Year | 12.71 | 15.89 | 11.53 | 13.84 | 106,871 | 2.45 | 19.26% |
| 3 Years | 6.46 | 15.89 | 3.00 | 11.96 | 119,877 | 8.70 | 134.64% |
| 5 Years | 5.89 | 15.89 | 1.49 | 8.77 | 161,584 | 9.27 | 157.34% |
Merrimack Pharmaceuticals Description
| Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products. |
